01641nas a2200181 4500000000100000008004100001653001700042653001700059653001200076653002100088100001400109245012400123856005100247300001100298490000700309520112900316022001401445 2016 d10aPrednisolone10aMethotrexate10aleprosy10aChronic neuritis1 aHossain D00aManagement of chronic neuritis with a combination regimen of lower doses prednisolone and methotrexate: a brief report. uhttps://leprosyreview.org/article/87/1/11-8121 a118-210 v873 a

INTRODUCTION: Recommended fixed duration prednisolone regimen was not found effective in the treatment of chronic neuritis. Alternate effective treatment was being sought to reduce the deformity in the field of leprosy.

OBJECTIVE: We wished to see whether a prolonged course of prednisolone and methotrexate could be of any help for them.

METHODOLOGY: In 2012-2014, an open pilot clinical study was undertaken where three chronic neuritic patients were treated with lower doses prednisolone and methotrexate for 12 months and a follow up period was delivered for 12 months. The study was undertaken in one of the outdoor clinics of the university.

RESULTS: Complete and permanent remission of neuritis was achieved with appreciable functional recovery. Few mild self-limiting side-effects from prednisolone were observed and there was no side-effects from methotrexate.

CONCLUSION: Prolonged course of prednisolone and methotrexate was found safe and effective in treating chronic neuritis.

 a0305-7518